Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 USD | -7.04% | -60.03% | -36.73% |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Apr. 23 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 1M | Sales 2025 * | 39.99M | Capitalization | 86.72M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -53M | EV / Sales 2024 * | 86.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.17 x |
P/E ratio 2024 * |
-1.41
x | P/E ratio 2025 * |
-1.91
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.9% |
Latest transcript on Abeona Therapeutics Inc.
1 day | -7.04% | ||
1 week | -60.03% | ||
Current month | -56.28% | ||
1 month | -58.34% | ||
3 months | -33.40% | ||
6 months | -20.75% | ||
Current year | -36.73% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 3.17 | -7.04% | 2,206,939 |
24-04-23 | 3.41 | -53.67% | 5,512,776 |
24-04-22 | 7.36 | -2.77% | 1,028,038 |
24-04-19 | 7.57 | +0.53% | 386,264 |
24-04-18 | 7.53 | -5.04% | 245,982 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.73% | 93.28M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- ABEO Stock